Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT04042051
Status:
TERMINATED
Last Update Posted:
2025-07-22
First Post:
2019-07-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Sponsor:
Cancer Trials Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-31
First Submit QC Date:
None
Study First Post Date:
2019-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-21
Last Update Post Date:
2025-07-22
Last Update Post Date Type:
ACTUAL